SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-22-000096
Filing Date
2022-07-21
Accepted
2022-07-21 08:00:35
Documents
12
Period of Report
2022-07-17
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K sesn-20220717.htm   iXBRL 8-K 37661
  Complete submission text file 0001485003-22-000096.txt   177381

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20220717.xsd EX-101.SCH 1902
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20220717_lab.xml EX-101.LAB 24849
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20220717_pre.xml EX-101.PRE 13046
6 EXTRACTED XBRL INSTANCE DOCUMENT sesn-20220717_htm.xml XML 11810
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 221095601
SIC: 2834 Pharmaceutical Preparations